

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 7.51878326 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.98455494 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.63444699 |
| 4 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 5.37883587 |
| 5 | facial nerve structural organization (GO:0021612) | 5.24080534 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.23918403 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.19858764 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.18919781 |
| 9 | vocalization behavior (GO:0071625) | 5.18317238 |
| 10 | glutamate secretion (GO:0014047) | 5.17854656 |
| 11 | positive regulation of synapse maturation (GO:0090129) | 5.16476915 |
| 12 | synaptic vesicle maturation (GO:0016188) | 5.00357884 |
| 13 | protein localization to synapse (GO:0035418) | 4.94742237 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.93837586 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.90852642 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.86027558 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.86017575 |
| 18 | tachykinin receptor signaling pathway (GO:0007217) | 4.78092514 |
| 19 | locomotory exploration behavior (GO:0035641) | 4.64705179 |
| 20 | cranial nerve structural organization (GO:0021604) | 4.56195886 |
| 21 | long-term memory (GO:0007616) | 4.54540717 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.49321607 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.46333769 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.40521495 |
| 25 | negative regulation of dendrite development (GO:2000171) | 4.21903932 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.20777119 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.18694848 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 4.15539880 |
| 29 | regulation of synapse maturation (GO:0090128) | 4.13387719 |
| 30 | neuron recognition (GO:0008038) | 4.07099050 |
| 31 | neurotransmitter secretion (GO:0007269) | 4.03709838 |
| 32 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.99649147 |
| 33 | postsynaptic membrane organization (GO:0001941) | 3.94376756 |
| 34 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.93112806 |
| 35 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.86880352 |
| 36 | neuronal action potential propagation (GO:0019227) | 3.85621517 |
| 37 | indole-containing compound catabolic process (GO:0042436) | 3.84972152 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 3.84972152 |
| 39 | tryptophan catabolic process (GO:0006569) | 3.84972152 |
| 40 | axonal fasciculation (GO:0007413) | 3.80877954 |
| 41 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.80044459 |
| 42 | synaptic transmission, glutamatergic (GO:0035249) | 3.77380685 |
| 43 | synaptic transmission, cholinergic (GO:0007271) | 3.72806912 |
| 44 | activation of protein kinase A activity (GO:0034199) | 3.71895315 |
| 45 | indolalkylamine metabolic process (GO:0006586) | 3.70822171 |
| 46 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.70019083 |
| 47 | exploration behavior (GO:0035640) | 3.68687071 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.67068817 |
| 49 | layer formation in cerebral cortex (GO:0021819) | 3.65212343 |
| 50 | behavioral defense response (GO:0002209) | 3.64656890 |
| 51 | behavioral fear response (GO:0001662) | 3.64656890 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.63646498 |
| 53 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.62584065 |
| 54 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.59415174 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.57933620 |
| 56 | kynurenine metabolic process (GO:0070189) | 3.57855361 |
| 57 | fucose catabolic process (GO:0019317) | 3.56481847 |
| 58 | L-fucose metabolic process (GO:0042354) | 3.56481847 |
| 59 | L-fucose catabolic process (GO:0042355) | 3.56481847 |
| 60 | dendritic spine morphogenesis (GO:0060997) | 3.56339935 |
| 61 | neuron-neuron synaptic transmission (GO:0007270) | 3.55591986 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.53046377 |
| 63 | presynaptic membrane assembly (GO:0097105) | 3.51421981 |
| 64 | proline transport (GO:0015824) | 3.51108487 |
| 65 | glutamate receptor signaling pathway (GO:0007215) | 3.50142477 |
| 66 | positive regulation of membrane potential (GO:0045838) | 3.47214835 |
| 67 | gamma-aminobutyric acid transport (GO:0015812) | 3.47095948 |
| 68 | presynaptic membrane organization (GO:0097090) | 3.46118946 |
| 69 | long-term synaptic potentiation (GO:0060291) | 3.44306354 |
| 70 | cell migration in hindbrain (GO:0021535) | 3.39128519 |
| 71 | learning (GO:0007612) | 3.38279601 |
| 72 | transmission of nerve impulse (GO:0019226) | 3.36032991 |
| 73 | regulation of synaptic plasticity (GO:0048167) | 3.35860782 |
| 74 | fear response (GO:0042596) | 3.35018273 |
| 75 | positive regulation of digestive system process (GO:0060456) | 3.34810582 |
| 76 | positive regulation of synaptic transmission (GO:0050806) | 3.32916618 |
| 77 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.32913738 |
| 78 | neuromuscular synaptic transmission (GO:0007274) | 3.30292295 |
| 79 | cerebellar granule cell differentiation (GO:0021707) | 3.28558721 |
| 80 | neuronal action potential (GO:0019228) | 3.26121053 |
| 81 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.25775556 |
| 82 | regulation of glutamate secretion (GO:0014048) | 3.25294657 |
| 83 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.24176033 |
| 84 | positive regulation of action potential (GO:0045760) | 3.23349473 |
| 85 | regulation of glucocorticoid secretion (GO:2000849) | 3.22675988 |
| 86 | serotonin metabolic process (GO:0042428) | 3.19531589 |
| 87 | neurotransmitter transport (GO:0006836) | 3.18909961 |
| 88 | positive regulation of neurotransmitter transport (GO:0051590) | 3.17887404 |
| 89 | platelet dense granule organization (GO:0060155) | 3.15730663 |
| 90 | behavioral response to ethanol (GO:0048149) | 3.15283196 |
| 91 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.13992763 |
| 92 | membrane depolarization during action potential (GO:0086010) | 3.13090821 |
| 93 | tryptophan metabolic process (GO:0006568) | 3.12745888 |
| 94 | reflex (GO:0060004) | 3.12061234 |
| 95 | regulation of vesicle fusion (GO:0031338) | 3.11529772 |
| 96 | regulation of neurotransmitter transport (GO:0051588) | 3.11162739 |
| 97 | indole-containing compound metabolic process (GO:0042430) | 3.10605904 |
| 98 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.10230397 |
| 99 | primary amino compound metabolic process (GO:1901160) | 3.09633090 |
| 100 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.09061982 |
| 101 | detection of light stimulus involved in visual perception (GO:0050908) | 3.06835277 |
| 102 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.06835277 |
| 103 | glycine transport (GO:0015816) | 3.06055439 |
| 104 | cellular ketone body metabolic process (GO:0046950) | 3.05828101 |
| 105 | positive regulation of synapse assembly (GO:0051965) | 3.05575916 |
| 106 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.05002129 |
| 107 | positive regulation of muscle cell apoptotic process (GO:0010661) | 3.04604204 |
| 108 | regulation of synaptic transmission (GO:0050804) | 3.04443320 |
| 109 | regulation of neurotransmitter uptake (GO:0051580) | 3.03528173 |
| 110 | mechanosensory behavior (GO:0007638) | 3.02898399 |
| 111 | * cerebellum development (GO:0021549) | 3.01950943 |
| 112 | heparin metabolic process (GO:0030202) | 3.00174731 |
| 113 | heparin biosynthetic process (GO:0030210) | 3.00174731 |
| 114 | negative regulation of microtubule polymerization (GO:0031115) | 2.99979667 |
| 115 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.99454163 |
| 116 | sympathetic nervous system development (GO:0048485) | 2.98948041 |
| 117 | associative learning (GO:0008306) | 2.97551208 |
| 118 | regulation of protein kinase A signaling (GO:0010738) | 2.95771809 |
| 119 | anatomical structure arrangement (GO:0048532) | 2.93620977 |
| 120 | regulation of neurotransmitter levels (GO:0001505) | 2.92471436 |
| 121 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.92346718 |
| 122 | positive regulation of growth hormone secretion (GO:0060124) | 2.90849611 |
| 123 | response to pheromone (GO:0019236) | 2.90576917 |
| 124 | protein localization to cilium (GO:0061512) | 2.88802178 |
| 125 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.88785526 |
| 126 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.88277124 |
| 127 | synaptic vesicle transport (GO:0048489) | 2.86720450 |
| 128 | establishment of synaptic vesicle localization (GO:0097480) | 2.86720450 |
| 129 | dendrite morphogenesis (GO:0048813) | 2.86337509 |
| 130 | central nervous system neuron axonogenesis (GO:0021955) | 2.86306237 |
| 131 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.83794398 |
| 132 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.83794398 |
| 133 | membrane depolarization (GO:0051899) | 2.83646849 |
| 134 | DNA deamination (GO:0045006) | 2.82754600 |
| 135 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.82510556 |
| 136 | startle response (GO:0001964) | 2.81887544 |
| 137 | positive regulation of amino acid transport (GO:0051957) | 2.81876118 |
| 138 | negative regulation of interleukin-17 production (GO:0032700) | 2.81179919 |
| 139 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.80319543 |
| 140 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.80319543 |
| 141 | auditory behavior (GO:0031223) | 2.79623100 |
| 142 | regulation of collateral sprouting (GO:0048670) | 2.79613583 |
| 143 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.79401761 |
| 144 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.78361914 |
| 145 | nucleobase catabolic process (GO:0046113) | 2.75280328 |
| 146 | adaptation of signaling pathway (GO:0023058) | 2.72492873 |
| 147 | ketone body metabolic process (GO:1902224) | 2.70416458 |
| 148 | spinal cord motor neuron differentiation (GO:0021522) | 2.69467562 |
| 149 | negative regulation of mast cell activation (GO:0033004) | 2.69442636 |
| 150 | cellular biogenic amine catabolic process (GO:0042402) | 2.68397916 |
| 151 | amine catabolic process (GO:0009310) | 2.68397916 |
| 152 | cellular response to ATP (GO:0071318) | 2.68079314 |
| 153 | sulfation (GO:0051923) | 2.65919928 |
| 154 | regulation of action potential (GO:0098900) | 2.63096090 |
| 155 | neural tube formation (GO:0001841) | 2.60742034 |
| 156 | protein polyglutamylation (GO:0018095) | 2.57774124 |
| 157 | retinal cone cell development (GO:0046549) | 2.56997663 |
| 158 | adult walking behavior (GO:0007628) | 2.55302586 |
| 159 | action potential (GO:0001508) | 2.50945787 |
| 160 | glycosphingolipid biosynthetic process (GO:0006688) | 2.50652563 |
| 161 | epithelial cilium movement (GO:0003351) | 2.50188876 |
| 162 | response to amphetamine (GO:0001975) | 2.49837704 |
| 163 | alanine transport (GO:0032328) | 2.49400159 |
| 164 | axoneme assembly (GO:0035082) | 2.48123102 |
| 165 | regulation of respiratory system process (GO:0044065) | 2.47667347 |
| 166 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.46903784 |
| 167 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.46903784 |
| 168 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.46903784 |
| 169 | nonmotile primary cilium assembly (GO:0035058) | 2.46862279 |
| 170 | cAMP catabolic process (GO:0006198) | 2.46671413 |
| 171 | cellular response to sterol (GO:0036315) | 2.45815737 |
| 172 | respiratory chain complex IV assembly (GO:0008535) | 2.45205404 |
| 173 | regulation of cilium movement (GO:0003352) | 2.40079486 |
| 174 | potassium ion transmembrane transport (GO:0071805) | 2.39731680 |
| 175 | cellular potassium ion transport (GO:0071804) | 2.39731680 |
| 176 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.39035354 |
| 177 | regulation of respiratory gaseous exchange (GO:0043576) | 2.38417863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.76812866 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.40515174 |
| 3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.18469627 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.17754495 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07398808 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06054051 |
| 7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.93429657 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.73962561 |
| 9 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.73678982 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.70836082 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.68027002 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.67731313 |
| 13 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65078503 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62711310 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.56255607 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53471763 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51893573 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51893573 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.50844621 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.49935308 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48920248 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.46664319 |
| 23 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46363257 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44262173 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33682813 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33584668 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.33291709 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.29901871 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.27660867 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.25948685 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.25342369 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.13861499 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01465294 |
| 34 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97497312 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80491624 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78585464 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78325336 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77969525 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77267165 |
| 40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.75670563 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.75406713 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.65157820 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60631390 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58811063 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55968491 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55409040 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50331318 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.49398431 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.47759585 |
| 50 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.47528633 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.47312365 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47039515 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46855311 |
| 54 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.46497024 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45348695 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44678906 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43586888 |
| 58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39684149 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39159921 |
| 60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36129283 |
| 61 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36089606 |
| 62 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32007834 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31356811 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.31000927 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.31000927 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30413547 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29775016 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29327999 |
| 69 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28548283 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28113478 |
| 71 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27401442 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24236450 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.23718003 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23485768 |
| 75 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23074517 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21323882 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20980589 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20875498 |
| 79 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19769064 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19760278 |
| 81 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18277942 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17825937 |
| 83 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17823977 |
| 84 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.17351486 |
| 85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16635914 |
| 86 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.15826504 |
| 87 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15096628 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15041557 |
| 89 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14989950 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14357807 |
| 91 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13297621 |
| 92 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.12394570 |
| 93 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11834306 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11632004 |
| 95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11443692 |
| 96 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11289580 |
| 97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10868276 |
| 98 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09970659 |
| 99 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.09959293 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.09959293 |
| 101 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09422820 |
| 102 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07705914 |
| 103 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.06819359 |
| 104 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.06210104 |
| 105 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05847067 |
| 106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03393578 |
| 107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03284985 |
| 108 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02782409 |
| 109 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01987677 |
| 110 | AR_19668381_ChIP-Seq_PC3_Human | 1.00622647 |
| 111 | JUN_21703547_ChIP-Seq_K562_Human | 1.00019505 |
| 112 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99638336 |
| 113 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98440484 |
| 114 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96073355 |
| 115 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94775393 |
| 116 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94236866 |
| 117 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93180142 |
| 118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92586174 |
| 119 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92560235 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92557504 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90053095 |
| 122 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89928328 |
| 123 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89758306 |
| 124 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89430069 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88182146 |
| 126 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87545624 |
| 127 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87001817 |
| 128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86852066 |
| 129 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86852066 |
| 130 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.86239864 |
| 131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85539788 |
| 132 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85329251 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84927715 |
| 134 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84550809 |
| 135 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82803815 |
| 136 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82764020 |
| 137 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81266466 |
| 138 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.80749022 |
| 139 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79146616 |
| 140 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.78980509 |
| 141 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.78714441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.63129417 |
| 2 | MP0003880_abnormal_central_pattern | 4.26367204 |
| 3 | MP0004270_analgesia | 3.84320084 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 3.75709209 |
| 5 | * MP0002063_abnormal_learning/memory/cond | 3.25711583 |
| 6 | MP0009745_abnormal_behavioral_response | 3.23141397 |
| 7 | MP0002735_abnormal_chemical_nociception | 3.14856608 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.10203136 |
| 9 | MP0005167_abnormal_blood-brain_barrier | 3.00776541 |
| 10 | * MP0002572_abnormal_emotion/affect_behav | 2.96081889 |
| 11 | MP0010386_abnormal_urinary_bladder | 2.94141021 |
| 12 | MP0002064_seizures | 2.89412777 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.89137690 |
| 14 | MP0002638_abnormal_pupillary_reflex | 2.73836180 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.67596609 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.61470133 |
| 17 | MP0003195_calcinosis | 2.60431556 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.46482935 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.45249336 |
| 20 | MP0000778_abnormal_nervous_system | 2.43616468 |
| 21 | MP0002736_abnormal_nociception_after | 2.41733744 |
| 22 | MP0009046_muscle_twitch | 2.36979715 |
| 23 | MP0008877_abnormal_DNA_methylation | 2.36657191 |
| 24 | * MP0002272_abnormal_nervous_system | 2.26741057 |
| 25 | MP0002822_catalepsy | 2.19150326 |
| 26 | MP0001970_abnormal_pain_threshold | 2.16392035 |
| 27 | MP0001486_abnormal_startle_reflex | 2.15178257 |
| 28 | MP0002733_abnormal_thermal_nociception | 2.13118164 |
| 29 | MP0001440_abnormal_grooming_behavior | 2.02511471 |
| 30 | MP0002184_abnormal_innervation | 2.02446055 |
| 31 | MP0006292_abnormal_olfactory_placode | 1.96786327 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.90641455 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.88928033 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.85861418 |
| 35 | MP0001984_abnormal_olfaction | 1.85445644 |
| 36 | MP0005253_abnormal_eye_physiology | 1.81832594 |
| 37 | MP0002653_abnormal_ependyma_morphology | 1.80334616 |
| 38 | MP0001188_hyperpigmentation | 1.75426761 |
| 39 | MP0003122_maternal_imprinting | 1.73236149 |
| 40 | MP0003787_abnormal_imprinting | 1.71835871 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.69485266 |
| 42 | MP0003879_abnormal_hair_cell | 1.66094827 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.64821807 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.61704464 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.60672550 |
| 46 | MP0002254_reproductive_system_inflammat | 1.60513728 |
| 47 | MP0004885_abnormal_endolymph | 1.55659803 |
| 48 | MP0008569_lethality_at_weaning | 1.55631324 |
| 49 | MP0002163_abnormal_gland_morphology | 1.51925548 |
| 50 | * MP0004924_abnormal_behavior | 1.50970379 |
| 51 | * MP0005386_behavior/neurological_phenoty | 1.50970379 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.49885416 |
| 53 | MP0005646_abnormal_pituitary_gland | 1.47698144 |
| 54 | MP0004858_abnormal_nervous_system | 1.45589649 |
| 55 | MP0004142_abnormal_muscle_tone | 1.42254551 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.41996121 |
| 57 | MP0003646_muscle_fatigue | 1.38716476 |
| 58 | * MP0002066_abnormal_motor_capabilities/c | 1.37064097 |
| 59 | MP0004043_abnormal_pH_regulation | 1.36698557 |
| 60 | * MP0002882_abnormal_neuron_morphology | 1.35777535 |
| 61 | MP0000955_abnormal_spinal_cord | 1.35205883 |
| 62 | MP0002938_white_spotting | 1.30687559 |
| 63 | MP0000013_abnormal_adipose_tissue | 1.28122838 |
| 64 | MP0001529_abnormal_vocalization | 1.25296482 |
| 65 | MP0005499_abnormal_olfactory_system | 1.23440254 |
| 66 | MP0005394_taste/olfaction_phenotype | 1.23440254 |
| 67 | MP0003136_yellow_coat_color | 1.21579337 |
| 68 | MP0002751_abnormal_autonomic_nervous | 1.19434377 |
| 69 | MP0004133_heterotaxia | 1.17988379 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 1.16996147 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 1.13398656 |
| 72 | MP0002152_abnormal_brain_morphology | 1.13332885 |
| 73 | MP0002102_abnormal_ear_morphology | 1.12905566 |
| 74 | MP0003633_abnormal_nervous_system | 1.10568428 |
| 75 | * MP0001905_abnormal_dopamine_level | 1.10538674 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.08567414 |
| 77 | MP0000538_abnormal_urinary_bladder | 1.03495312 |
| 78 | MP0000427_abnormal_hair_cycle | 1.00912408 |
| 79 | MP0000372_irregular_coat_pigmentation | 0.99623034 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.98050158 |
| 81 | MP0003329_amyloid_beta_deposits | 0.97057883 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.96747808 |
| 83 | MP0003632_abnormal_nervous_system | 0.96227583 |
| 84 | MP0004147_increased_porphyrin_level | 0.95995565 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.93905664 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.92839022 |
| 87 | MP0003011_delayed_dark_adaptation | 0.91168048 |
| 88 | MP0008789_abnormal_olfactory_epithelium | 0.90277105 |
| 89 | MP0001963_abnormal_hearing_physiology | 0.87119106 |
| 90 | MP0005535_abnormal_body_temperature | 0.86713052 |
| 91 | MP0004215_abnormal_myocardial_fiber | 0.86544304 |
| 92 | MP0001664_abnormal_digestion | 0.85414578 |
| 93 | * MP0005195_abnormal_posterior_eye | 0.83371859 |
| 94 | MP0003631_nervous_system_phenotype | 0.83121872 |
| 95 | MP0003890_abnormal_embryonic-extraembry | 0.82325336 |
| 96 | MP0004742_abnormal_vestibular_system | 0.81335721 |
| 97 | MP0008874_decreased_physiological_sensi | 0.80752392 |
| 98 | MP0003119_abnormal_digestive_system | 0.80643703 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.80582114 |
| 100 | MP0008872_abnormal_physiological_respon | 0.79368599 |
| 101 | MP0003283_abnormal_digestive_organ | 0.78367270 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.76041021 |
| 103 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75988760 |
| 104 | MP0002928_abnormal_bile_duct | 0.75911078 |
| 105 | MP0000751_myopathy | 0.75321929 |
| 106 | MP0003861_abnormal_nervous_system | 0.75139854 |
| 107 | MP0004145_abnormal_muscle_electrophysio | 0.73805923 |
| 108 | MP0001485_abnormal_pinna_reflex | 0.72647459 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.69726849 |
| 110 | MP0005448_abnormal_energy_balance | 0.69337587 |
| 111 | MP0004085_abnormal_heartbeat | 0.68387910 |
| 112 | MP0001944_abnormal_pancreas_morphology | 0.67919091 |
| 113 | * MP0002752_abnormal_somatic_nervous | 0.67592956 |
| 114 | MP0004233_abnormal_muscle_weight | 0.67035657 |
| 115 | MP0005409_darkened_coat_color | 0.66849357 |
| 116 | MP0002229_neurodegeneration | 0.65960332 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.65231929 |
| 118 | MP0003938_abnormal_ear_development | 0.61218185 |
| 119 | MP0000026_abnormal_inner_ear | 0.60651368 |
| 120 | MP0003123_paternal_imprinting | 0.58142933 |
| 121 | MP0003956_abnormal_body_size | 0.57618201 |
| 122 | MP0003634_abnormal_glial_cell | 0.57544711 |
| 123 | MP0003121_genomic_imprinting | 0.56954914 |
| 124 | MP0010770_preweaning_lethality | 0.56057254 |
| 125 | MP0002082_postnatal_lethality | 0.56057254 |
| 126 | MP0001177_atelectasis | 0.54035719 |
| 127 | MP0010769_abnormal_survival | 0.53332960 |
| 128 | MP0005187_abnormal_penis_morphology | 0.52996352 |
| 129 | MP0001943_abnormal_respiration | 0.52573791 |
| 130 | MP0010768_mortality/aging | 0.50466009 |
| 131 | MP0005551_abnormal_eye_electrophysiolog | 0.50097661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.16977358 |
| 2 | Myokymia (HP:0002411) | 5.93679654 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.44575548 |
| 4 | Hyperventilation (HP:0002883) | 5.25762579 |
| 5 | Visual hallucinations (HP:0002367) | 5.07520830 |
| 6 | Focal seizures (HP:0007359) | 4.42314748 |
| 7 | Pancreatic cysts (HP:0001737) | 3.94756998 |
| 8 | Atonic seizures (HP:0010819) | 3.86471182 |
| 9 | Febrile seizures (HP:0002373) | 3.76441765 |
| 10 | Poor eye contact (HP:0000817) | 3.61400649 |
| 11 | Broad-based gait (HP:0002136) | 3.60124437 |
| 12 | Abnormality of midbrain morphology (HP:0002418) | 3.54655143 |
| 13 | Molar tooth sign on MRI (HP:0002419) | 3.54655143 |
| 14 | Pancreatic fibrosis (HP:0100732) | 3.39064166 |
| 15 | Congenital stationary night blindness (HP:0007642) | 3.38320826 |
| 16 | Obstructive sleep apnea (HP:0002870) | 3.36091188 |
| 17 | Nephronophthisis (HP:0000090) | 3.31488953 |
| 18 | Epileptiform EEG discharges (HP:0011182) | 3.27136181 |
| 19 | True hermaphroditism (HP:0010459) | 3.26845059 |
| 20 | Absence seizures (HP:0002121) | 3.25478550 |
| 21 | Depression (HP:0000716) | 3.24980683 |
| 22 | EEG with generalized epileptiform discharges (HP:0011198) | 3.16928963 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 3.15604472 |
| 24 | Stereotypic behavior (HP:0000733) | 3.14220147 |
| 25 | Anxiety (HP:0000739) | 3.10928463 |
| 26 | Abnormal hair whorl (HP:0010721) | 3.10092067 |
| 27 | Impaired social interactions (HP:0000735) | 3.06256785 |
| 28 | Abnormal social behavior (HP:0012433) | 3.06256785 |
| 29 | Hypsarrhythmia (HP:0002521) | 3.05759359 |
| 30 | Type II lissencephaly (HP:0007260) | 3.03561046 |
| 31 | Sleep apnea (HP:0010535) | 2.98031461 |
| 32 | Ankle clonus (HP:0011448) | 2.96156389 |
| 33 | Pheochromocytoma (HP:0002666) | 2.95450674 |
| 34 | Dialeptic seizures (HP:0011146) | 2.93938578 |
| 35 | Generalized tonic-clonic seizures (HP:0002069) | 2.91983287 |
| 36 | Abnormality of the renal medulla (HP:0100957) | 2.90977024 |
| 37 | Failure to thrive in infancy (HP:0001531) | 2.82102233 |
| 38 | Agitation (HP:0000713) | 2.79267748 |
| 39 | Amblyopia (HP:0000646) | 2.78579634 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 2.77883633 |
| 41 | Abnormality of the renal cortex (HP:0011035) | 2.76713996 |
| 42 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.75841445 |
| 43 | Genetic anticipation (HP:0003743) | 2.75723840 |
| 44 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.75272410 |
| 45 | Attenuation of retinal blood vessels (HP:0007843) | 2.74295471 |
| 46 | Truncal ataxia (HP:0002078) | 2.71880093 |
| 47 | Protruding tongue (HP:0010808) | 2.71063624 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 2.65128030 |
| 49 | Excessive salivation (HP:0003781) | 2.64672464 |
| 50 | Drooling (HP:0002307) | 2.64672464 |
| 51 | Abolished electroretinogram (ERG) (HP:0000550) | 2.64378092 |
| 52 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.63620379 |
| 53 | Abnormal eating behavior (HP:0100738) | 2.61960659 |
| 54 | Blue irides (HP:0000635) | 2.57989056 |
| 55 | Poor suck (HP:0002033) | 2.55149934 |
| 56 | Intestinal atresia (HP:0011100) | 2.52359522 |
| 57 | Inability to walk (HP:0002540) | 2.51142698 |
| 58 | Abnormality of the lower motor neuron (HP:0002366) | 2.50992870 |
| 59 | Spastic gait (HP:0002064) | 2.50762303 |
| 60 | Urinary urgency (HP:0000012) | 2.48140093 |
| 61 | Menstrual irregularities (HP:0000858) | 2.46689381 |
| 62 | Progressive inability to walk (HP:0002505) | 2.46057655 |
| 63 | Large for gestational age (HP:0001520) | 2.43762064 |
| 64 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.43497481 |
| 65 | Nonprogressive disorder (HP:0003680) | 2.40553609 |
| 66 | Cystic liver disease (HP:0006706) | 2.34239867 |
| 67 | Polydipsia (HP:0001959) | 2.33841686 |
| 68 | Abnormal drinking behavior (HP:0030082) | 2.33841686 |
| 69 | Growth hormone excess (HP:0000845) | 2.31876919 |
| 70 | Congenital sensorineural hearing impairment (HP:0008527) | 2.31808686 |
| 71 | Spinal canal stenosis (HP:0003416) | 2.28434965 |
| 72 | Delusions (HP:0000746) | 2.27970754 |
| 73 | Cerebellar dysplasia (HP:0007033) | 2.27671212 |
| 74 | Gait imbalance (HP:0002141) | 2.27641593 |
| 75 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.26420857 |
| 76 | Abnormality of alanine metabolism (HP:0010916) | 2.26285693 |
| 77 | Hyperalaninemia (HP:0003348) | 2.26285693 |
| 78 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26285693 |
| 79 | Hypoventilation (HP:0002791) | 2.26153383 |
| 80 | Scanning speech (HP:0002168) | 2.25460787 |
| 81 | Action tremor (HP:0002345) | 2.24792610 |
| 82 | Hyperthyroidism (HP:0000836) | 2.24628012 |
| 83 | Hypothermia (HP:0002045) | 2.24484574 |
| 84 | Lissencephaly (HP:0001339) | 2.24380724 |
| 85 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.23784300 |
| 86 | Acute lymphatic leukemia (HP:0006721) | 2.23694373 |
| 87 | Limb dystonia (HP:0002451) | 2.23652411 |
| 88 | Keratoconus (HP:0000563) | 2.23513737 |
| 89 | Increased corneal curvature (HP:0100692) | 2.23513737 |
| 90 | Torticollis (HP:0000473) | 2.23334280 |
| 91 | Polyphagia (HP:0002591) | 2.22655363 |
| 92 | Focal dystonia (HP:0004373) | 2.22372708 |
| 93 | Chronic hepatic failure (HP:0100626) | 2.21479369 |
| 94 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.19769275 |
| 95 | Psychosis (HP:0000709) | 2.18308496 |
| 96 | Severe muscular hypotonia (HP:0006829) | 2.17560056 |
| 97 | Absent speech (HP:0001344) | 2.16990460 |
| 98 | Tubular atrophy (HP:0000092) | 2.16819816 |
| 99 | Esotropia (HP:0000565) | 2.15901149 |
| 100 | Genital tract atresia (HP:0001827) | 2.15094222 |
| 101 | Postural instability (HP:0002172) | 2.14779688 |
| 102 | Bradykinesia (HP:0002067) | 2.13189532 |
| 103 | Optic nerve hypoplasia (HP:0000609) | 2.11752494 |
| 104 | Amyotrophic lateral sclerosis (HP:0007354) | 2.11417859 |
| 105 | Pendular nystagmus (HP:0012043) | 2.11331931 |
| 106 | Oligodactyly (hands) (HP:0001180) | 2.10614300 |
| 107 | Vaginal atresia (HP:0000148) | 2.10312213 |
| 108 | Papilledema (HP:0001085) | 2.09811367 |
| 109 | Sporadic (HP:0003745) | 2.09290844 |
| 110 | Tachypnea (HP:0002789) | 2.09137538 |
| 111 | Gaze-evoked nystagmus (HP:0000640) | 2.07800549 |
| 112 | Decreased circulating renin level (HP:0003351) | 2.07539081 |
| 113 | Furrowed tongue (HP:0000221) | 2.04541316 |
| 114 | Ketoacidosis (HP:0001993) | 2.04403099 |
| 115 | Impaired pain sensation (HP:0007328) | 2.01587944 |
| 116 | Abnormality of pain sensation (HP:0010832) | 2.01587944 |
| 117 | Methylmalonic aciduria (HP:0012120) | 2.01352249 |
| 118 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.00908576 |
| 119 | Methylmalonic acidemia (HP:0002912) | 2.00548427 |
| 120 | Renal cortical cysts (HP:0000803) | 1.99878056 |
| 121 | Macroglossia (HP:0000158) | 1.97627746 |
| 122 | Progressive microcephaly (HP:0000253) | 1.96389243 |
| 123 | Incomplete penetrance (HP:0003829) | 1.95796689 |
| 124 | Congenital hepatic fibrosis (HP:0002612) | 1.93068550 |
| 125 | Medial flaring of the eyebrow (HP:0010747) | 1.92439579 |
| 126 | Neuroblastic tumors (HP:0004376) | 1.92295882 |
| 127 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.92295882 |
| 128 | Neuroblastoma (HP:0003006) | 1.92295882 |
| 129 | Primitive neuroectodermal tumor (HP:0030065) | 1.92295882 |
| 130 | Polyuria (HP:0000103) | 1.92202217 |
| 131 | Craniofacial dystonia (HP:0012179) | 1.91573317 |
| 132 | Status epilepticus (HP:0002133) | 1.91213441 |
| 133 | Autism (HP:0000717) | 1.90352110 |
| 134 | Pointed chin (HP:0000307) | 1.90265631 |
| 135 | Patellar aplasia (HP:0006443) | 1.89488362 |
| 136 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.89075069 |
| 137 | Disproportionate short-trunk short stature (HP:0003521) | 1.88706758 |
| 138 | Muscular hypotonia of the trunk (HP:0008936) | 1.87699485 |
| 139 | Nephrogenic diabetes insipidus (HP:0009806) | 1.87596112 |
| 140 | Hemiparesis (HP:0001269) | 1.87528030 |
| 141 | Fetal akinesia sequence (HP:0001989) | 1.87074395 |
| 142 | Congenital primary aphakia (HP:0007707) | 1.86744957 |
| 143 | Gait ataxia (HP:0002066) | 1.86160518 |
| 144 | Dysmetria (HP:0001310) | 1.85423905 |
| 145 | Lower limb muscle weakness (HP:0007340) | 1.85406116 |
| 146 | Megalencephaly (HP:0001355) | 1.85256481 |
| 147 | Clumsiness (HP:0002312) | 1.85001961 |
| 148 | Hypoplasia of the pons (HP:0012110) | 1.84736889 |
| 149 | Mutism (HP:0002300) | 1.84667386 |
| 150 | Open mouth (HP:0000194) | 1.83006447 |
| 151 | Testicular neoplasm (HP:0010788) | 1.81930845 |
| 152 | Impaired smooth pursuit (HP:0007772) | 1.81286610 |
| 153 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.80856769 |
| 154 | Heterochromia iridis (HP:0001100) | 1.79725090 |
| 155 | Anencephaly (HP:0002323) | 1.78969986 |
| 156 | Sclerocornea (HP:0000647) | 1.78928789 |
| 157 | Chorioretinal atrophy (HP:0000533) | 1.77625106 |
| 158 | Abnormality of the pons (HP:0007361) | 1.76308823 |
| 159 | Abnormality of the labia minora (HP:0012880) | 1.76258574 |
| 160 | Decreased central vision (HP:0007663) | 1.75602143 |
| 161 | Congenital, generalized hypertrichosis (HP:0004540) | 1.75566483 |
| 162 | Birth length less than 3rd percentile (HP:0003561) | 1.75145120 |
| 163 | Retinal dysplasia (HP:0007973) | 1.74515729 |
| 164 | Tubulointerstitial fibrosis (HP:0005576) | 1.73366475 |
| 165 | Absent/shortened dynein arms (HP:0200106) | 1.72497174 |
| 166 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.72497174 |
| 167 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.70445991 |
| 168 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.70445991 |
| 169 | Ketosis (HP:0001946) | 1.68660592 |
| 170 | Pachygyria (HP:0001302) | 1.67713527 |
| 171 | Male pseudohermaphroditism (HP:0000037) | 1.67091265 |
| 172 | Widely spaced teeth (HP:0000687) | 1.67035010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.03996446 |
| 2 | GRK1 | 5.19905446 |
| 3 | NTRK3 | 4.34757968 |
| 4 | CASK | 3.55943296 |
| 5 | MARK1 | 3.32782547 |
| 6 | MAP3K12 | 3.10844376 |
| 7 | CDK19 | 3.08012599 |
| 8 | EPHA4 | 3.00734112 |
| 9 | DAPK2 | 2.98523131 |
| 10 | TLK1 | 2.62716107 |
| 11 | RIPK4 | 2.60699729 |
| 12 | DAPK1 | 2.58623593 |
| 13 | BMPR1B | 2.51047349 |
| 14 | FLT3 | 2.50469106 |
| 15 | MAP3K4 | 2.48444187 |
| 16 | ACVR1B | 2.47438085 |
| 17 | MAP2K7 | 2.45899657 |
| 18 | MAP3K9 | 2.33942607 |
| 19 | WNK3 | 2.24525132 |
| 20 | TNIK | 2.24447094 |
| 21 | KIT | 2.18774815 |
| 22 | MAP4K2 | 2.14121526 |
| 23 | MINK1 | 2.05170029 |
| 24 | ZAK | 2.04695222 |
| 25 | KSR1 | 1.98428246 |
| 26 | INSRR | 1.85357357 |
| 27 | KSR2 | 1.82177305 |
| 28 | PINK1 | 1.81416850 |
| 29 | CCNB1 | 1.74542870 |
| 30 | UHMK1 | 1.63776421 |
| 31 | MAP2K4 | 1.58840696 |
| 32 | MAPK13 | 1.43226295 |
| 33 | CAMKK1 | 1.35527223 |
| 34 | ARAF | 1.35035528 |
| 35 | WNK4 | 1.32662468 |
| 36 | CAMKK2 | 1.31011463 |
| 37 | RAF1 | 1.30492752 |
| 38 | NTRK2 | 1.30482218 |
| 39 | PLK2 | 1.26211758 |
| 40 | SIK2 | 1.25687080 |
| 41 | GRK5 | 1.24289182 |
| 42 | NUAK1 | 1.23812666 |
| 43 | CDK5 | 1.22586520 |
| 44 | FES | 1.21593355 |
| 45 | PRPF4B | 1.20798416 |
| 46 | PAK6 | 1.17954428 |
| 47 | CSF1R | 1.17645165 |
| 48 | MAPK15 | 1.14848428 |
| 49 | SCYL2 | 1.14733731 |
| 50 | MKNK2 | 1.13314652 |
| 51 | NTRK1 | 1.13284268 |
| 52 | PNCK | 1.11142124 |
| 53 | * ADRBK2 | 1.09062513 |
| 54 | STK16 | 1.05356398 |
| 55 | PKN1 | 1.04753479 |
| 56 | TAOK3 | 1.02772495 |
| 57 | MAP3K2 | 1.01300469 |
| 58 | PRKCE | 0.95945485 |
| 59 | STK38L | 0.94271687 |
| 60 | CSNK1G1 | 0.89588969 |
| 61 | MAP2K6 | 0.86102526 |
| 62 | EPHB2 | 0.85201485 |
| 63 | STK39 | 0.85180924 |
| 64 | SGK2 | 0.81964210 |
| 65 | GRK7 | 0.80688031 |
| 66 | SGK223 | 0.79160077 |
| 67 | SGK494 | 0.79160077 |
| 68 | YES1 | 0.78951910 |
| 69 | PRKCG | 0.78277132 |
| 70 | DAPK3 | 0.77690836 |
| 71 | SIK3 | 0.74651813 |
| 72 | TXK | 0.74644747 |
| 73 | DYRK2 | 0.71132796 |
| 74 | DYRK1A | 0.71020241 |
| 75 | TRIM28 | 0.69795834 |
| 76 | OXSR1 | 0.69091959 |
| 77 | FGFR2 | 0.68307751 |
| 78 | CSNK1G2 | 0.67079131 |
| 79 | RPS6KA2 | 0.66457156 |
| 80 | CDK18 | 0.65524828 |
| 81 | CAMK4 | 0.65347058 |
| 82 | CAMK1 | 0.65109076 |
| 83 | ADRBK1 | 0.63513813 |
| 84 | TSSK6 | 0.62977573 |
| 85 | MARK2 | 0.62713739 |
| 86 | MATK | 0.62455633 |
| 87 | CDK15 | 0.61777233 |
| 88 | CDK14 | 0.61435479 |
| 89 | STK11 | 0.61132102 |
| 90 | CDK8 | 0.59029764 |
| 91 | TGFBR1 | 0.57121729 |
| 92 | BRAF | 0.55079736 |
| 93 | CAMK2A | 0.55056124 |
| 94 | CDK11A | 0.54464447 |
| 95 | CAMK2B | 0.53300630 |
| 96 | SGK3 | 0.52545943 |
| 97 | CHUK | 0.51693225 |
| 98 | MUSK | 0.50638478 |
| 99 | TNK2 | 0.50110941 |
| 100 | RET | 0.48087577 |
| 101 | MAP3K1 | 0.47697725 |
| 102 | CSNK1G3 | 0.47115439 |
| 103 | GRK6 | 0.46212263 |
| 104 | AKT3 | 0.45934632 |
| 105 | PRKACA | 0.45856620 |
| 106 | IRAK1 | 0.45476124 |
| 107 | PRKCH | 0.44382950 |
| 108 | PTK2B | 0.43748707 |
| 109 | PIK3CA | 0.43192717 |
| 110 | VRK1 | 0.41730866 |
| 111 | HIPK2 | 0.41710590 |
| 112 | BCR | 0.41406989 |
| 113 | MAP3K7 | 0.41106966 |
| 114 | CAMK1G | 0.41062417 |
| 115 | CSNK1A1 | 0.40952177 |
| 116 | RPS6KA5 | 0.40025824 |
| 117 | FGR | 0.39905690 |
| 118 | SYK | 0.38708735 |
| 119 | CSNK1D | 0.38571896 |
| 120 | NLK | 0.38076036 |
| 121 | PRKAA1 | 0.37669877 |
| 122 | PRKCQ | 0.37614341 |
| 123 | ERBB2 | 0.36989892 |
| 124 | TAOK1 | 0.36580221 |
| 125 | PIM2 | 0.36508171 |
| 126 | MAP2K1 | 0.36323081 |
| 127 | SGK1 | 0.35865023 |
| 128 | MAPKAPK5 | 0.35738246 |
| 129 | CDK3 | 0.35486890 |
| 130 | MAP3K6 | 0.34815828 |
| 131 | BMPR2 | 0.34739536 |
| 132 | PRKG1 | 0.34553137 |
| 133 | ERBB3 | 0.33306382 |
| 134 | PDK1 | 0.32926171 |
| 135 | FER | 0.31661523 |
| 136 | PRKAA2 | 0.31445150 |
| 137 | CAMK1D | 0.31378723 |
| 138 | MAP4K1 | 0.31350384 |
| 139 | CSNK1A1L | 0.31061360 |
| 140 | LIMK1 | 0.29679679 |
| 141 | IKBKB | 0.29552403 |
| 142 | PRKCZ | 0.29028414 |
| 143 | PRKCA | 0.28680519 |
| 144 | NME1 | 0.28405329 |
| 145 | STK24 | 0.27821090 |
| 146 | MST4 | 0.27191380 |
| 147 | ROCK2 | 0.24923561 |
| 148 | PHKG1 | 0.23373154 |
| 149 | PHKG2 | 0.23373154 |
| 150 | PAK3 | 0.21321867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.78297125 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.34152207 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.08186477 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.80341782 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.67199865 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.66628989 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.65475660 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.59227612 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 2.50896046 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46912055 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.43419663 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40579920 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.36156205 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.27147191 |
| 15 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.16426281 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.14889808 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.06753887 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 2.01269849 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.91421252 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88345875 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87824759 |
| 22 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.85927559 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.85469915 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.82154885 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.80202362 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.75968262 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.73765378 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.73288058 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72664733 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.68393401 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68123152 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65951338 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.62900018 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.60947454 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60034930 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56163055 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52459925 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.47135208 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36708040 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36316946 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.35387550 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34989321 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.29361900 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27977274 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16085078 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.13641690 |
| 47 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13512726 |
| 48 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13147342 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10591635 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.05837491 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05579884 |
| 52 | Protein export_Homo sapiens_hsa03060 | 1.04776559 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 1.01113343 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00154142 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99967324 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97951894 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96973604 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95905551 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95851831 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.95319124 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94981223 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93963793 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93600957 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.92072232 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91526711 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84789931 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82331434 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82043619 |
| 69 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81833315 |
| 70 | Alcoholism_Homo sapiens_hsa05034 | 0.81763788 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81715478 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.81386766 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78816844 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77652217 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76453705 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76404895 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74665666 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72341947 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72315368 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.72233270 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.70991779 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70009837 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69475593 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68656244 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68621459 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68534519 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68393510 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68095165 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.67255792 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67185201 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66482942 |
| 92 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.66335305 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.65545101 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64439582 |
| 95 | RNA polymerase_Homo sapiens_hsa03020 | 0.63791303 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62282125 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62053367 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61892825 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60862230 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59661540 |
| 101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58987012 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57896686 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55840373 |
| 104 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55665383 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55314242 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55036476 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54134163 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54021244 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53509542 |
| 110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53086534 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51996449 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51905786 |
| 113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51683055 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49016430 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48360786 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48057838 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47287744 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46813815 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.45315248 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45248400 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44839028 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44694396 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44582758 |
| 124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42378208 |
| 125 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42135180 |
| 126 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41814681 |
| 127 | Allograft rejection_Homo sapiens_hsa05330 | 0.40900378 |
| 128 | RNA degradation_Homo sapiens_hsa03018 | 0.39971214 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38997364 |
| 130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38545247 |
| 131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38176293 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35468332 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35395936 |
| 134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35379461 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34675572 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.34444703 |
| 137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32428830 |
| 138 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32095660 |
| 139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31906168 |
| 140 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31704479 |
| 141 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31224370 |
| 142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30868955 |
| 143 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30423047 |
| 144 | Pertussis_Homo sapiens_hsa05133 | 0.29521396 |
| 145 | Purine metabolism_Homo sapiens_hsa00230 | 0.28378697 |
| 146 | Melanoma_Homo sapiens_hsa05218 | 0.28361809 |
| 147 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28041832 |
| 148 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28021760 |
| 149 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27618239 |
| 150 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26638985 |
| 151 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.25497967 |

